BOEHRINGER INGELHEIM FDA Approval NDA 015874

NDA 015874

BOEHRINGER INGELHEIM

FDA Drug Application

Application #015874

Application Sponsors

NDA 015874BOEHRINGER INGELHEIM

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL20MG0ALUPENTMETAPROTERENOL SULFATE
002TABLET;ORAL10MG0ALUPENTMETAPROTERENOL SULFATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1974-05-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1974-12-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1974-12-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1974-12-19PRIORITY
LABELING; LabelingSUPPL6AP1976-09-23
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1976-03-11PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1976-07-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1976-04-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1976-07-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1976-07-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1977-08-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1976-11-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1976-11-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1976-12-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1976-10-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1980-05-05PRIORITY
LABELING; LabelingSUPPL18AP1977-08-08
LABELING; LabelingSUPPL19AP1978-06-28
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1979-06-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1980-01-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1980-09-11PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1981-04-07PRIORITY
LABELING; LabelingSUPPL24AP2002-11-12
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1981-06-24PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1982-02-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1983-05-05PRIORITY
LABELING; LabelingSUPPL28AP1983-05-05
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1983-01-05PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1985-12-10PRIORITY
LABELING; LabelingSUPPL31AP1983-11-10
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1985-12-10PRIORITY
LABELING; LabelingSUPPL33AP1984-05-04
LABELING; LabelingSUPPL34AP1986-02-14
LABELING; LabelingSUPPL35AP1992-04-28
LABELING; LabelingSUPPL36AP1991-03-11
LABELING; LabelingSUPPL37AP2002-11-12STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL29Null0
SUPPL30Null0
SUPPL32Null0

CDER Filings

BOEHRINGER INGELHEIM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 15874
            [companyName] => BOEHRINGER INGELHEIM
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALUPENT","activeIngredients":"METAPROTERENOL SULFATE","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ALUPENT","activeIngredients":"METAPROTERENOL SULFATE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ALUPENT","submission":"METAPROTERENOL SULFATE","actionType":"20MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ALUPENT","submission":"METAPROTERENOL SULFATE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.